[Platelet-activating factor (PAF) antagonists].
Terasawa
M
M
Research Laboratories, Yoshitomi Pharmaceutical Industries, Ltd., Fukuoka, Japan.
D000818:Animals; D001381:Azepines / Q000378:metabolism / Q000494:pharmacology*; D001667:Binding, Competitive; D004224:Diterpenes; D005663:Furans / Q000378:metabolism / Q000494:pharmacology; D046934:Ginkgolides; D006801:Humans; D007783:Lactones / Q000378:metabolism / Q000494:pharmacology*; D010742:Phospholipid Ethers / Q000378:metabolism / Q000494:pharmacology; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors* / Q000378:metabolism; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled; D014230:Triazoles / Q000378:metabolism / Q000494:pharmacology*
D001381:Azepines; D004224:Diterpenes; D005663:Furans; D046934:Ginkgolides; D007783:Lactones; D010742:Phospholipid Ethers; D010972:Platelet Activating Factor; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D014230:Triazoles; C039351:platelet activating factor receptor; C052518:WEB 2086; C058295:ginkgolide C; C037913:CV 3988; C047504:2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran